Pain News and Research

Latest Pain News and Research

Diamyd Medical to divide operations into two business areas

In her comments in today's year end report, Elisabeth Lindner, President and CEO of Diamyd Medical, states that the company has decided to divide its operations into two business areas beginning with the new 2010/2011 fiscal year; Diabetes and Pain.

22 Oct 2010

Research suggests lowering cholesterol can reduce benign prostatic hyperplasia

A cholesterol-lowering drug reduced the enlarged prostates of hamsters to the same extent as a drug commonly used to treat benign prostatic hyperplasia (BPH), report researchers at Children's Hospital Boston and their colleagues in the October issue of the Journal of Urology. Together, the drugs worked even better.

22 Oct 2010

Novartis releases study results on oral calcitonin for treatment of osteoarthritis: Unigene Laboratories

Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.

22 Oct 2010

Health Canada approves ULORIC to lower serum uric acid levels in patients with gout

Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.

21 Oct 2010

Highlights of Frontiers in Optics 2010/Laser Science XXVI Meeting

Scientists and engineers from around the world will gather on the shores of Lake Ontario in Rochester, N.Y. next week to discuss some of the latest breakthroughs in lasers and optics and their applications to cutting-edge science, the development of new materials, and medicine.

21 Oct 2010

Researcher creates novel theory about chronic depression

Chronic depression is an adaptive, reparative neurobiological process gone wrong, say two University of California, San Diego School of Medicine researchers, positing in a new theory that the debilitating mental state originates from more ancient mechanisms used by the body to deal with physical injury, such as pain, tissue repair and convalescent behavior.

21 Oct 2010

Lubricin reduces wear to bone cartilage

A team of researchers in North Carolina has discovered that lubricin, a synovial fluid glycoprotein, reduces wear to bone cartilage. This result, which has implications for the treatment of sufferers of osteoarthritis, will be presented today at the AVS 57th International Symposium & Exhibition, taking place this week at the Albuquerque Convention Center in New Mexico.

21 Oct 2010

ASTRO selects Scripps Clinic nurse for 2010 Excellence Award

The American Society for Radiation Oncology (ASTRO) recently selected Elizabeth A. Brunton, R.N., M.S.N., O.C.N., of Scripps Clinic in La Jolla, Calif., as the recipient of the 2010 ASTRO Nurse Excellence Award.

21 Oct 2010

MAP Pharmaceuticals to present nine analyses on LEVADEX for migraine therapy at 2010 EHMTIC congress

MAP Pharmaceuticals, Inc. today announced that the Company will present nine analyses relating to its LEVADEX™ orally inhaled migraine therapy product candidate, including analysis from the FREEDOM-301 Phase 3 trial, at the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.

21 Oct 2010

BREAKYL drug receives European approval

BioDelivery Sciences International, Inc. and Meda today announced approval of BEMA Fentanyl in Europe via the Decentralized Procedure, with Germany acting as Reference Member State.

20 Oct 2010

NMT releases new device for treatment of post-operative nausea

Neurowave Medical Technologies™ today announced the release of an innovative new device for the treatment of post-operative nausea, medically referred to as emesis. Reletex™ is a novel transdermal neuromodulation device that is non-invasive and drug-free, and has been demonstrated to alleviate nausea when used as an adjunct to anti-emetics.

20 Oct 2010

Pfizer enters partnership with Teuto to develop, commercialize generic medicines

Pfizer Inc. announced today that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to develop and commercialize generic medicines.

20 Oct 2010

New brush optrode improves optical scanning of brain activity

One of the main techniques for measuring and monitoring mental activity, called functional near infrared spectroscopy (fNIRS), can often be impaired because a person's hair gets in the way. But now, thanks to a team of researchers at the University of Texas at Dallas and the University of Texas at Arlington, a novel device called a "brush optrode" is providing increased sensitivity with fiber tips designed to thread through hair to enhance scalp contact.

20 Oct 2010

$More studies needed on bisphosphonates therapy and fracture risk$

More studies needed on bisphosphonates therapy and fracture risk

On October 13, the Food and Drug Administration published a warning to doctors and patients about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs called bisphosphonates. This warning was much awaited in the light of a report published in the American Journal of Bone and Mineral Research in September titled "Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research."

20 Oct 2010

National Pap Test Campaign for cervical cancer diagnosis

The Federation of Medical Women of Canada (FMWC) and the Society of Obstetricians and Gynaecologists of Canada (SOGC) are ready to launch this year's National Pap Test Campaign, to take place during National Cervical Cancer Awareness Week. From October 24th to 30th, over 100 health-care professionals across Canada are taking a stand against cervical cancer by hosting public Pap test clinics in their community.

20 Oct 2010

Researchers to develop tailor-made pain management strategies for chronic pain

Research presented at this year's American Society of Anesthesiologists Annual Meeting offers new data in the quest to develop tailor-made pain management strategies based upon a patient's genetic predisposition and other important factors.

20 Oct 2010

Nitric oxide inhalation reduces pain in sickle cell disease patients

Inhaling nitric oxide appears to safely and effectively reduce pain crises in adults with sickle cell disease, researchers report.

20 Oct 2010

Study finds different activity patterns of genes in brain of individuals with different genetic backgrounds

Researchers at the Allen Institute for Brain Science have found that the same genes have different activity patterns in the brain in individuals with different genetic backgrounds. These findings may help to explain individual differences in the effectiveness and side-effect profiles of therapeutic drugs and thus have implications for personalized medicine. The study is available in this week's online early edition of the Proceedings of the National Academy of Sciences (www.pnas.org).

20 Oct 2010

New disease pathways involving more than one cell type lead to Type 1 Gaucher disease: Study

Researchers at Yale School of Medicine have found that new disease pathways involving more than one cell type leads to Type 1 Gaucher disease, a rare genetic disorder in which fatty substances called glycosphingolipids accumulate in cells, resulting in liver/spleen enlargement, osteoporosis, bone pain, and increased risk of cancer and Parkinson's disease.

20 Oct 2010

Dexamethasone improves quality of life after laparoscopic gallbladder surgery

A study presented at the American Society of Anesthesiologists 2010 Annual Meeting in San Diego seems to confirm that a single, small dose of the steroid dexamethasone improves the post-surgical quality of life of patients receiving laparoscopic gallbladder surgery.

20 Oct 2010

Pain News and Research

Latest Pain News and Research

Diamyd Medical to divide operations into two business areas

Research suggests lowering cholesterol can reduce benign prostatic hyperplasia

Novartis releases study results on oral calcitonin for treatment of osteoarthritis: Unigene Laboratories

Health Canada approves ULORIC to lower serum uric acid levels in patients with gout

Highlights of Frontiers in Optics 2010/Laser Science XXVI Meeting

Researcher creates novel theory about chronic depression

Lubricin reduces wear to bone cartilage

ASTRO selects Scripps Clinic nurse for 2010 Excellence Award

MAP Pharmaceuticals to present nine analyses on LEVADEX for migraine therapy at 2010 EHMTIC congress

BREAKYL drug receives European approval

NMT releases new device for treatment of post-operative nausea

Pfizer enters partnership with Teuto to develop, commercialize generic medicines

New brush optrode improves optical scanning of brain activity

More studies needed on bisphosphonates therapy and fracture risk

National Pap Test Campaign for cervical cancer diagnosis

Researchers to develop tailor-made pain management strategies for chronic pain

Nitric oxide inhalation reduces pain in sickle cell disease patients

Study finds different activity patterns of genes in brain of individuals with different genetic backgrounds

New disease pathways involving more than one cell type lead to Type 1 Gaucher disease: Study

Dexamethasone improves quality of life after laparoscopic gallbladder surgery

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in